Brief: Hua Medicine Says Unit To Acquire 100% Stake In Nanjing Ascendrare Pharmaceutical Technology
18/11/2022 06:01
Nov 18 (Reuters) - Hua Medicine 2552.HK :
* UNIT TO ACQUIRE 100% STAKE IN NANJING ASCENDRARE
PHARMACEUTICAL
TECHNOLOGY AT CONSIDERATION OF RMB1.0 MILLION
Further company coverage: 2552.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hua Medicine
See all newsBrief: Hua Medicine Expects Loss Of RMB30.2 Mln For HY
Brief: Hua Medicine Posts Profit For The Year RMB1.11 Billion
Brief: Hua Medicine Says Dorzagliatin Approved For Marketing In Hong Kong SAR
Brief: Hua Medicine Posts H1 Revenue Of RMB 217.4 Million
Brief: Hua Medicine Expects RMB1,184.1 Million Profit For HY